ofatumumab : Franchise Herald

ofatumumab

ofatumumab

Glaxo is Selling its Rights to its Autoimmune Treating Drug to Novartis for $1 Billion, Divests its Remaining Rights in the Drug

GlaxoSmithKline Plc has just announced that it will be selling its rights in ofatumumab, a drug that treats autoimmune disease, including multiple sclerosis, to Novartis AG for more than $1.03 billion, according to a press release issued by Glaxo.

Just In

Costco's Legendary Return Policy Strikes Again: 2017 Purchase Refunded in Full

Costco Wholesale

Dollar Tree Announces Closure of 35 Stores in Ohio, Final Sales Underway

Sorry We're Closed Note

Walmart Continues Downsize with Latest Store Closure, 105 Employees Affected

Shopping trolley

Steak 'N Shake Introduces Facial Recognition Payment System, Sparks Customer Outrage

Sliced Steak

Chili’s Restaurant Closes Permanently, Locals Reflect on Memories

Fixed chairs

Most Read

1

Walmart Continues Downsize with Latest Store Closure, 105 Employees Affected

Shopping trolley

2

True Value Bids Farewell: Iconic Store Location Closes Permanently, Liquidation Sales Offer Up to 50% Off

Locked door

3

Target's New Age Check Policy Sparks Outrage Among Mall Shoppers

Supermarket stalls

4

Costco's Secret Slice: Employee Confessions and How Shoppers Can Score These Pizzas Too

People picking a slice of pizza

5

Kroger and Albertsons to Sell Nearly 600 Stores in Strategic Move Towards Merger

shopping carts